Callan Family Office’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.49M Sell
32,715
-3,036
-8% -$707K 0.15% 152
2025
Q4
$9.59M Buy
35,751
+9,197
+35% +$2.34M 0.21% 96
2025
Q3
$6.55M Sell
26,554
-7,555
-22% -$1.97M 0.21% 110
2025
Q2
$10.2M Buy
34,109
+13,449
+65% +$4.1M 0.32% 59
2025
Q1
$6.45M Sell
20,660
-1,283
-6% -$453K 0.48% 43
2024
Q4
$7.72M Buy
21,943
+19,353
+747% +$6.97M 0.49% 35
2024
Q3
$916K Buy
2,590
+1,092
+73% +$359K 0.15% 74
2024
Q2
$455K Buy
1,498
+246
+20% +$75.4K 0.09% 93
2024
Q1
$434K Buy
1,252
+89
+8% +$32.4K 0.1% 62
2023
Q4
$408K Buy
1,163
+50
+4% +$16.1K 0.1% 63
2023
Q3
$342K Sell
1,113
-1,061
-49% -$334K 0.09% 68
2023
Q2
$671K Sell
2,174
-184
-8% -$53.5K 0.18% 56
2023
Q1
$674K Buy
2,358
+74
+3% +$20.2K 0.16% 78
2022
Q4
$609K Buy
+2,284
New +$632K 0.2% 52

Other funds holding ACN

Callan Family Office's ACN Position: Q1 2026 in Review

Callan Family Office reduced its Accenture (ACN) stake by 8.5% in Q1 2026, selling an estimated $707K and leaving 32,715 shares worth $6.49M. The position accounts for 0.15% of the portfolio, ranked #152.

Callan Family Office first reported a position in ACN in Q4 2022 and has held it in 14 quarters since. The position peaked at $10.2M in Q2 2025. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Callan Family Office held 32,715 shares of Accenture worth $6.49M as of Q1 2026.
  • Callan Family Office sold 3,036 Accenture shares in Q1 2026, an estimated $707K.
  • Accenture made up 0.15% of Callan Family Office's portfolio in Q1 2026, its #152 holding.
  • Callan Family Office first reported a position in Accenture in Q4 2022 and has held it in 14 quarters since.
  • Callan Family Office's Accenture position peaked at $10.2M in Q2 2025.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.